NCT00459524View on ClinicalTrials.gov

Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

CompletedOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Interventions
BEHAVIORAL

Questionnaire

Questionnaires taking about 30 minutes to complete.

BEHAVIORAL

Neurocognitive Testing

Neurocognitive testing lasting 30 minutes. Patients will be asked to complete certain tasks that require the use of their hands, eyes, and ears.

Trial Locations (1)

77030

U.T.M.D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00459524 - Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) | Biotech Hunter | Biotech Hunter